THE BIONIC EYE
Journal Title: International Journal of Pharmaceutical Development & Technology - Year 2015, Vol 5, Issue 1
Abstract
ABSTRACT Aim of bionic eye is to restore vision to patients who have gone blind due to macular degeneration or retinitis pigmentosa. In the past 20 years, biotechnology has become the fastest-growing area of scientific research, with new devices going into clinical trials at a breakneck pace.2013 has been a year of turning science fiction into reality. One technology that immediately comes to mind is the bionic eye. While in the works for years, the first artificial retina and surgical implant procedure were just recently approved by the FDA. Designed by Second Sight, the Argus II Retinal Prosthesis System uses camera-mounted glasses to turn visual information into data that can be wirelessly transmitted to the bionic implant on the eye. The device has been specifically designed for – and testing with – patients who suffer from retinitis pigmentosa: an inherited degenerative disease leading to severe deterioration of sight or total blindness. Around 1.5 million people worldwide suffer from the condition, including 100,000 America. The Argus II Retinal Prosthesis System can provide sight -- the detection of light -- to people who have gone blind from degenerative eye diseases like macular degeneration and retinitis pigmentosa. Ten percent of people over the age of 55 suffer from various stages of macular degeneration. Retinitis pigmentosa is an inherited disease that affects about 1.5 million people around the globe. Both diseases damage the eyes' photoreceptors, the cells at the back of the retina that perceive light patterns and pass them on to the brain in the form of nerve impulses, where the impulse patterns are then interpreted as images. The Argus II system takes the place of these photoreceptors. Keywords: Bionic eye, Retinitis pigmentosa, Photoreceptors
Authors and Affiliations
Satya Mounika CH. V. V.
Keywords
Related Articles
- EP ID EP154194
- DOI -
- Views 112
- Downloads 0
REGULATORY STRATEGIES FOR FILING OF NDA IN ICH COUNTRIES (US, EUROPE and JAPAN)
ABSTRACT Developing new drugs requires great amount of research work in Chemistry, Manufacturing, Controls, preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the...
FORMULATION AND EVALUATION OF GLIMEPIRIDE MICROSPHERES
The present study is an attempt to formulate microspheres of Glimepiride, an orally administered ant-diabetic drug with a view of improving its oral bioavailability and giving a prolonged release of drug, where h...
DESIGN AND EVALUATION OF GELATIN MICROSPHERES CONTAINING DICLOFENAC SODIUM
Microspheres are characteristically free flowing powders consisting of proteins or synthetic polymers which are biodegradable in nature and ideally having a particle size less than 200 μm. The present study is ai...
FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FINASTERIDE
The aim of the present investigation was to develop oral controlled release matrix tablet formulations of Finasteride using Eudragit and Hydroxypropyl methylcellulose (HPMC) as a hydrophilic release retardant pol...
RECENT TRENDS IN INSULIN DRUG DELIVERY SYSTEM
The advanced methods of insulin delivery systems would gradually progress toward physiological insulin replacement and reduce the long-term complications of diabetes mellitus. Thus, a feasible alternative route f...